Ravulizumab was successful in improving blood health, kidney function and quality of life while maintaining eGFR in pediatric and adult patients with atypical hemolytic uremic syndrome, according to published data.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045